349.23 USD
+5.63 (+1.64%)
Overall AMGN gets a fundamental rating of 5 out of 10. We evaluated AMGN against 525 industry peers in the Biotechnology industry. AMGN has an excellent profitability rating, but there are concerns on its financial health. AMGN has a decent growth rate and is not valued too expensively. AMGN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
- AMGN had positive earnings in the past year.
- In the past year AMGN had a positive cash flow from operations.
- In the past 5 years AMGN has always been profitable.
- AMGN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 7.77%, AMGN belongs to the top of the industry, outperforming 93.14% of the companies in the same industry.
- AMGN has a Return On Equity of 72.82%. This is amongst the best in the industry. AMGN outperforms 99.05% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 15.39%, AMGN belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
- AMGN had an Average Return On Invested Capital over the past 3 years of 13.04%. This is significantly below the industry average of 18.07%.
- The 3 year average ROIC (13.04%) for AMGN is below the current ROIC(15.39%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROIC | 15.39% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
1.3 Margins
- With an excellent Profit Margin value of 19.47%, AMGN belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
- AMGN's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 33.57%, AMGN belongs to the top of the industry, outperforming 97.33% of the companies in the same industry.
- AMGN's Operating Margin has declined in the last couple of years.
- The Gross Margin of AMGN (72.06%) is better than 82.67% of its industry peers.
- AMGN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% |
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMGN is creating some value.
- The number of shares outstanding for AMGN has been increased compared to 1 year ago.
- The number of shares outstanding for AMGN has been reduced compared to 5 years ago.
- Compared to 1 year ago, AMGN has an improved debt to assets ratio.
2.2 Solvency
- The Debt to FCF ratio of AMGN is 4.28, which is a neutral value as it means it would take AMGN, 4.28 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of AMGN (4.28) is better than 92.00% of its industry peers.
- A Debt/Equity ratio of 5.45 is on the high side and indicates that AMGN has dependencies on debt financing.
- AMGN has a worse Debt to Equity ratio (5.45) than 80.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Altman-Z | N/A |
ROIC/WACC1.77
WACC8.71%
2.3 Liquidity
- A Current Ratio of 1.28 indicates that AMGN should not have too much problems paying its short term obligations.
- AMGN has a worse Current ratio (1.28) than 83.05% of its industry peers.
- A Quick Ratio of 0.99 indicates that AMGN may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.99, AMGN is doing worse than 85.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
- AMGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.79%, which is quite good.
- The Earnings Per Share has been growing slightly by 5.97% on average over the past years.
- Looking at the last year, AMGN shows a quite strong growth in Revenue. The Revenue has grown by 10.56% in the last year.
- AMGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.43% yearly.
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
3.2 Future
- The Earnings Per Share is expected to grow by 4.77% on average over the next years.
- The Revenue is expected to grow by 3.63% on average over the next years.
EPS Next Y9.46%
EPS Next 2Y6.31%
EPS Next 3Y5.32%
EPS Next 5Y4.77%
Revenue Next Year9.4%
Revenue Next 2Y5.49%
Revenue Next 3Y4.57%
Revenue Next 5Y3.63%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 15.97, the valuation of AMGN can be described as correct.
- Based on the Price/Earnings ratio, AMGN is valued cheaper than 96.00% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.32. AMGN is valued slightly cheaper when compared to this.
- Based on the Price/Forward Earnings ratio of 15.59, the valuation of AMGN can be described as correct.
- 95.81% of the companies in the same industry are more expensive than AMGN, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of AMGN to the average of the S&P500 Index (24.30), we can say AMGN is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.97 | ||
| Fwd PE | 15.59 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, AMGN is valued cheaply inside the industry as 95.62% of the companies are valued more expensively.
- 96.95% of the companies in the same industry are more expensive than AMGN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.74 | ||
| EV/EBITDA | 13.03 |
4.3 Compensation for Growth
- AMGN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- AMGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.69
PEG (5Y)2.67
EPS Next 2Y6.31%
EPS Next 3Y5.32%
5. Dividend
5.1 Amount
- AMGN has a Yearly Dividend Yield of 3.05%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 1.18, AMGN pays a better dividend. On top of this AMGN pays more dividend than 98.86% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.86, AMGN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.05% |
5.2 History
- The dividend of AMGN is nicely growing with an annual growth rate of 9.41%!
- AMGN has been paying a dividend for at least 10 years, so it has a reliable track record.
- AMGN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.41%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
- 17.20% of the earnings are spent on dividend by AMGN. This is a low number and sustainable payout ratio.
- AMGN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP17.2%
EPS Next 2Y6.31%
EPS Next 3Y5.32%
NASDAQ:AMGN (1/22/2026, 11:06:09 AM)
349.23
+5.63 (+1.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners83.87%
Inst Owner Change-0.01%
Ins Owners0.06%
Ins Owner Change-0.77%
Market Cap188.05B
Revenue(TTM)35.97B
Net Income(TTM)7.00B
Analysts72.2
Price Target338.94 (-2.95%)
Short Float %2.79%
Short Ratio5.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.05% |
Yearly Dividend9.01
Dividend Growth(5Y)9.41%
DP17.2%
Div Incr Years13
Div Non Decr Years13
Ex-Date02-13 2026-02-13 (2.52)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.96%
Min EPS beat(2)10.28%
Max EPS beat(2)11.64%
EPS beat(4)4
Avg EPS beat(4)9.04%
Min EPS beat(4)2.49%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)5.13%
EPS beat(12)10
Avg EPS beat(12)4.44%
EPS beat(16)14
Avg EPS beat(16)4.21%
Revenue beat(2)2
Avg Revenue beat(2)2.59%
Min Revenue beat(2)0.68%
Max Revenue beat(2)4.49%
Revenue beat(4)3
Avg Revenue beat(4)1.17%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.49%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)4
Avg Revenue beat(12)-0.48%
Revenue beat(16)5
Avg Revenue beat(16)-0.54%
PT rev (1m)1.76%
PT rev (3m)5.94%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)-7.61%
EPS NY rev (1m)0.02%
EPS NY rev (3m)0.93%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)1.03%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.97 | ||
| Fwd PE | 15.59 | ||
| P/S | 5.23 | ||
| P/FCF | 14.74 | ||
| P/OCF | 14.33 | ||
| P/B | 19.55 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.03 |
EPS(TTM)21.87
EY6.26%
EPS(NY)22.4
Fwd EY6.41%
FCF(TTM)23.69
FCFY6.78%
OCF(TTM)24.38
OCFY6.98%
SpS66.8
BVpS17.86
TBVpS-59.79
PEG (NY)1.69
PEG (5Y)2.67
Graham Number93.76
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROCE | 17.67% | ||
| ROIC | 15.39% | ||
| ROICexc | 17.86% | ||
| ROICexgc | 61.56% | ||
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% | ||
| FCFM | 35.46% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
ROICexc(3y)15.77%
ROICexc(5y)17.27%
ROICexgc(3y)75.76%
ROICexgc(5y)77.1%
ROCE(3y)14.97%
ROCE(5y)16.28%
ROICexgc growth 3Y3.26%
ROICexgc growth 5Y-18.2%
ROICexc growth 3Y-8.67%
ROICexc growth 5Y-7.85%
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
F-Score7
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.3% | ||
| Profit Quality | 182.08% | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | N/A |
F-Score7
WACC8.71%
ROIC/WACC1.77
Cap/Depr(3y)24.77%
Cap/Depr(5y)23.42%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.31%
Profit Quality(3y)165.92%
Profit Quality(5y)155.23%
High Growth Momentum
Growth
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
EPS Next Y9.46%
EPS Next 2Y6.31%
EPS Next 3Y5.32%
EPS Next 5Y4.77%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
Revenue Next Year9.4%
Revenue Next 2Y5.49%
Revenue Next 3Y4.57%
Revenue Next 5Y3.63%
EBIT growth 1Y93.73%
EBIT growth 3Y1.84%
EBIT growth 5Y-0.13%
EBIT Next Year42.71%
EBIT Next 3Y11.36%
EBIT Next 5Y7.69%
FCF growth 1Y36%
FCF growth 3Y7.44%
FCF growth 5Y4.03%
OCF growth 1Y24.04%
OCF growth 3Y7.45%
OCF growth 5Y4.66%
AMGEN INC / AMGN FAQ
Can you provide the ChartMill fundamental rating for AMGEN INC?
ChartMill assigns a fundamental rating of 5 / 10 to AMGN.
What is the valuation status of AMGEN INC (AMGN) stock?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (AMGN). This can be considered as Fairly Valued.
What is the profitability of AMGN stock?
AMGEN INC (AMGN) has a profitability rating of 7 / 10.
How financially healthy is AMGEN INC?
The financial health rating of AMGEN INC (AMGN) is 3 / 10.
What is the earnings growth outlook for AMGEN INC?
The Earnings per Share (EPS) of AMGEN INC (AMGN) is expected to grow by 9.46% in the next year.